Association of Caffeine Intake with All-cause and Cardiovascular Mortality in Diabetes and Prediabetes

Overview

Journal Diabetol Metab Syndr

Publisher Biomed Central

Specialty Endocrinology

Date 2024 Jul 26

PMID 39061109

Authors

Haipeng Yao

Lamei Li

Xiabo Wang

Zhongqun Wang

Affiliations

Soon will be listed here.

Abstract

Backgroud: The association between caffeine intake and mortality in prediabetes and diabetes is not well defined. This study was designed to investigate the association between caffeine intake and all-cause mortality and cardiovascular disease (CVD) mortality in adults with prediabetes and diabetes in the United States.

Methods: This analysis included 18,914 adult patients with diabetes and prediabetes from the National Health and Nutrition Examination Survey (NHANES) 2003-2018. Follow-up extended to December 31, 2019. Weighted Cox proportional hazards regression models were used to estimate the hazard ratios (HR) and 95% confidence intervals (CI) for all-cause mortality and CVD mortality.

Results: During 142,460 person-years of follow-up, there were 3,166 cases of all-cause mortality and 1,031 cases of CVD mortality recorded. In the fully adjusted models, caffeine intake showed a significant dose-response association with the risk of all-cause mortality and CVD mortality in individuals with diabetes and prediabetes. When comparing extreme quartiles of caffeine intake, the multivariable-adjusted hazard ratio for all-cause mortality was 0.78 (0.67-0.91) (P for trend = 0.007); however, there was no significant association with the risk of CVD mortality. Results remained consistent in stratified analyses by sex, age, race/ethnicity, education level, family income-poverty ratio, BMI, hypertension, smoking status, alcohol intake, and HEI-2015.

Conclusions: This study suggests that caffeine intake is significantly inversely associated with the risk of all-cause mortality in individuals with diabetes and prediabetes. In individuals with prediabetes, there is also a significant inverse association between caffeine intake and CVD events, but this association is not present in those with diabetes.

References

Ma L, Hu Y, Alperet D, Liu G, Malik V, Manson J . Beverage consumption and mortality among adults with type 2 diabetes: prospective cohort study. BMJ. 2023; 381:e073406. PMC: 10114037. DOI: 10.1136/bmj-2022-073406. View

Visseren F, Mach F, Smulders Y, Carballo D, Koskinas K, Back M . [2021 ESC Guidelines on cardiovascular disease prevention in clinical practice]. G Ital Cardiol (Rome). 2022; 23(6 Suppl 1):e3-e115. DOI: 10.1714/3808.37926. View

Thayer J, Yamamoto S, Brosschot J . The relationship of autonomic imbalance, heart rate variability and cardiovascular disease risk factors. Int J Cardiol. 2009; 141(2):122-31. DOI: 10.1016/j.ijcard.2009.09.543. View

Zhang W, Lopez-Garcia E, Li T, Hu F, van Dam R . Coffee consumption and risk of cardiovascular events and all-cause mortality among women with type 2 diabetes. Diabetologia. 2009; 52(5):810-7. PMC: 2666099. DOI: 10.1007/s00125-009-1311-1. View

Claypool K, Patel C . Prevalence of Fatty Liver Disease is Driven by Prediabetes and Diabetes: US NHANES 2017-2018. Clin Gastroenterol Hepatol. 2021; 20(3):712-713. PMC: 10291529. DOI: 10.1016/j.cgh.2021.05.003. View

Gunter M, Murphy N, Cross A, Dossus L, Dartois L, Fagherazzi G . Coffee Drinking and Mortality in 10 European Countries: A Multinational Cohort Study. Ann Intern Med. 2017; 167(4):236-247. PMC: 5788283. DOI: 10.7326/M16-2945. View

Legrady D, Dyer A, SHEKELLE R, Stamler J, Liu K, Paul O . Coffee consumption and mortality in the Chicago Western Electric Company Study. Am J Epidemiol. 1987; 126(5):803-12. DOI: 10.1093/oxfordjournals.aje.a114717. View

Levey A, Stevens L, Schmid C, Zhang Y, Castro 3rd A, Feldman H . A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009; 150(9):604-12. PMC: 2763564. DOI: 10.7326/0003-4819-150-9-200905050-00006. View

Carlstrom M, Larsson S . Coffee consumption and reduced risk of developing type 2 diabetes: a systematic review with meta-analysis. Nutr Rev. 2018; 76(6):395-417. DOI: 10.1093/nutrit/nuy014. View

10.

Tverdal A, Stensvold I, Solvoll K, Foss O, Bjartveit K . Coffee consumption and death from coronary heart disease in middle aged Norwegian men and women. BMJ. 1990; 300(6724):566-9. PMC: 1662349. DOI: 10.1136/bmj.300.6724.566. View

11.

Kamiyama M, Moon J, Jang H, Shibamoto T . Role of degradation products of chlorogenic acid in the antioxidant activity of roasted coffee. J Agric Food Chem. 2015; 63(7):1996-2005. DOI: 10.1021/jf5060563. View

12.

Neves J, Leitao L, Magrico R, Vieira M, Viegas Dias C, Oliveira A . Caffeine Consumption and Mortality in Diabetes: An Analysis of NHANES 1999-2010. Front Endocrinol (Lausanne). 2018; 9:547. PMC: 6158371. DOI: 10.3389/fendo.2018.00547. View

13.

Loftfield E, Freedman N, Graubard B, Guertin K, Black A, Huang W . Association of Coffee Consumption With Overall and Cause-Specific Mortality in a Large US Prospective Cohort Study. Am J Epidemiol. 2015; 182(12):1010-22. PMC: 5875735. DOI: 10.1093/aje/kwv146. View

14.

Han Y, Hu H, Li Q, Deng Z, Liu D . Triglyceride glucose-body mass index and the risk of progression to diabetes from prediabetes: A 5-year cohort study in Chinese adults. Front Public Health. 2023; 11:1028461. PMC: 9935616. DOI: 10.3389/fpubh.2023.1028461. View

15.

Jiang X, Zhang D, Jiang W . Coffee and caffeine intake and incidence of type 2 diabetes mellitus: a meta-analysis of prospective studies. Eur J Nutr. 2013; 53(1):25-38. DOI: 10.1007/s00394-013-0603-x. View

16.

Gupta A, Atanasov A, Li Y, Kumar N, Bishayee A . Chlorogenic acid for cancer prevention and therapy: Current status on efficacy and mechanisms of action. Pharmacol Res. 2022; 186:106505. DOI: 10.1016/j.phrs.2022.106505. View

17.

de Roos B, Sawyer J, Katan M, Rudel L . Validity of animal models for the cholesterol-raising effects of coffee diterpenes in human subjects. Proc Nutr Soc. 1999; 58(3):551-7. DOI: 10.1017/s0029665199000725. View

18.

Kim J, Jung K, Jeong H . Suppressive effects of the kahweol and cafestol on cyclooxygenase-2 expression in macrophages. FEBS Lett. 2004; 569(1-3):321-6. DOI: 10.1016/j.febslet.2004.05.070. View

19.

Moco S, Martin F, Rezzi S . Metabolomics view on gut microbiome modulation by polyphenol-rich foods. J Proteome Res. 2012; 11(10):4781-90. DOI: 10.1021/pr300581s. View

20.

van Dam R, Hu F, Willett W . Coffee, Caffeine, and Health. N Engl J Med. 2020; 383(4):369-378. DOI: 10.1056/NEJMra1816604. View